112271-44-0

Upstream product

• 109346-00-1 3-(4-methoxyphenyl)propiolamide 
• 2258-42-6 formyl acetic anhydride 
• 862263-27-2 [(Z)-3-(4-Methoxy-phenyl)-1-[1-(4-methoxy-phenyl)-meth-(Z)-ylidene]-2-(2-trimethylsilanyl-ethoxycarbonylamino)-allyl]-carbamic acid 2-trimethylsilanyl-ethyl ester 
• 1558-67-4 formic anhydride 
• 7515-17-5 methyl 3-(4-methoxyphenyl)propynoate 
• 862263-31-8 N-[(E)-1-{tri(n-butyl)stannyl}-2-(4-methoxyphenyl)vinyl]formamide 
• 186581-53-3 diazomethane 
• 133883-86-0 (Z,Z)-N,N'-<1-<(4-hydroxyphenyl)methylene>-2-<(4-methoxyphenyl)methylene>-1,2-ethanediyl>bis-formamide 
• 4464-33-9 xanthocillin X dimethyl ether 
• 64-19-7 acetic acid 
• 2227-57-8 3-(4-methoxyphenyl)propynoic acid 

Downstream Products

• 4464-33-9 xanthocillin X dimethyl ether 

Relevant academic research and scientific papers

FORMYLATED XANTHOCILLIN ANALOGUES AS NEUROPROTECTIVE AGENTS

Formylated xanthocillin analogs can be used in the treatment of neurodegenerative diseases. The analogs can be prepared synthetically, and at least some of the analogs can be obtained from a microorganism strain of the Penicillium chrysogenum species.

FORMYLATED XANTHOCILLIN ANALOGUES AS NEUROPROTECTANTS

The present invention relates to formylated xanthocillin analogues for use in the treatment of neurodegenerative diseases, to some of said analogues, as well as to methods for obtaining them and pharmaceutical composition comprising them. The invention al

ALPHA-SUBSTITUTED VINYLTIN COMPOUND

To provide α-substituted vinyltin useful for the search for function-developing substances such as pharmaceuticals/agrichemicals and functional materials and for the construction of a compound library. An α-substituted vinyltin compound represented by the

The first stereoselective total synthesis of antiviral antibiotic, xanthocillin X dimethylether and its stereoisomer

Xanthocillin X dimethylether (1) has been stereoselectively synthesized from the propiolic acid 6 through an oxidative rearrangement of the stannyl vinyl amide 27 to give the vinyl isocyanate 30 and a homocoupling of the stannyl N-formylenamine 31.